Utah Medical Products, Inc. (UTMD) is a Healthcare stock trading at $71.40 (as of 2026-08-20), with a market capitalization of $227.34M and a trailing P/E of 21.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices used in healthcare settings, including labor and delivery accessories and systems, neonatal respiratory hoods, and blood pressure monitoring equipment. The company also supplies products such as catheters, dialysis and urinary drainage sets, electrosurgical generators and electrodes, and related surgical instruments for clinical use.
Utah Medical Products, Inc. (UTMD) develops, manufactures, and distributes medical devices and accessories used in areas like labor and delivery, infant respiratory care, blood pressure monitoring, and dialysis and feeding, and it makes money from net sales of these products to healthcare customers.
The profit model is tightly linked to turning product into sales while controlling working capital, since investors can monitor Days in Trade Receivables and Average Inventory Turns, and the company reports relatively strong gross margin and operating margin.
| Net Sales | $0.0B |
Business quality (Mixed): High reported margins for the latest quarter, but revenue is very small on the provided scale, so working capital conversion and execution across its specialized medical device portfolio are key watch points.
Valuation: At 19× earnings, UTMD trades 40% below the Medical Equipment average (32×). Note: one-time items can distort reported P/E.
| Price | $71.40 |
| Market Cap | $227.34M |
| P/E Ratio | 21.6 |
| EV / EBITDA | 11.8 |
| Price / Book | 1.86 |
| Price / Sales | 6.35 |
| FCF Yield | 9.3% |
| DCF Value (model) | $76.71 |
| DCF Upside vs Price | 7.4% |
| Revenue (TTM) | $38.52M |
| Net Margin | 29.3% |
| Revenue Growth (YoY) | -14.3% |
| EPS Growth (YoY) | -10.6% |
| FCF Growth (YoY) | -40.5% |
| Altman Z-Score | 44.70 (safe) |
| Piotroski F-Score | 5/9 (moderate) |
| Stock P/E | 21.6 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | 0.0% |
| vs Industry | -34.3% |
| Top Institutional Holder | BRANDES INVESTMENT PARTNERS, LP ($27.85M) |
| Institutional Holders Tracked | 10 |
| Sector | Healthcare |
| Industry | Medical Equipment |
| CEO | Kevin L. Cornwell |
| Employees | 155 |
| Country | US |
| IPO Date | 1999-03-08 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.